Wells Fargo’s Kaleido Biosciences, Inc. Common Stock KLDO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
Sell
-5,183
Closed -$8K 7667
2022
Q1
$8K Sell
5,183
-7,839
-60% -$12.1K ﹤0.01% 6019
2021
Q4
$31K Buy
13,022
+12,086
+1,291% +$28.8K ﹤0.01% 5697
2021
Q3
$6K Buy
936
+325
+53% +$2.08K ﹤0.01% 6023
2021
Q2
$5K Sell
611
-518
-46% -$4.24K ﹤0.01% 6032
2021
Q1
$9K Sell
1,129
-12,164
-92% -$97K ﹤0.01% 6024
2020
Q4
$121K Buy
13,293
+7
+0.1% +$64 ﹤0.01% 5130
2020
Q3
$147K Sell
13,286
-2,211
-14% -$24.5K ﹤0.01% 4926
2020
Q2
$115K Buy
15,497
+4,806
+45% +$35.7K ﹤0.01% 4963
2020
Q1
$66K Sell
10,691
-543
-5% -$3.35K ﹤0.01% 5040
2019
Q4
$56K Buy
11,234
+500
+5% +$2.49K ﹤0.01% 5233
2019
Q3
$81K Buy
10,734
+10,695
+27,423% +$80.7K ﹤0.01% 5157
2019
Q2
$0 Buy
+39
New ﹤0.01% 6320